Compounds > citalopram

citalopram and n-methylaspartate

citalopram has been researched along with n-methylaspartate in 5 studies

Research

Studies (5)

TimeframeStudies, this research(%)All Research%
pre-19901 (20.00)18.7374
1990's1 (20.00)18.2507
2000's0 (0.00)29.6817
2010's3 (60.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Barzizza, A; Maura, G; Raiteri, M1
Christenson, J; Franck, J; Grillner, S1
Nowak, G; Pilc, A; Poleszak, E; Popik, P; Siwek, A; Szewczyk, B; Wolak, M1
Björkholm, C; Feltmann, K; Jardemark, K; Konradsson-Geuken, Å; Malmerfelt, A; Marcus, MM; Möller, A; Påhlsson, N; Schilström, B; Svensson, TH1
Barygin, OI; Belinskaya, DA; Nagaeva, EI; Shestakova, NN; Tikhonov, DB; Vanchakova, NP1

Other Studies

5 other study(ies) available for citalopram and n-methylaspartate

ArticleYear
Activation of presynaptic 5-hydroxytryptamine1-like receptors on glutamatergic terminals inhibits N-methyl-D-aspartate-induced cyclic GMP production in rat cerebellar slices.
    The Journal of pharmacology and experimental therapeutics, 1991, Volume: 257, Issue:3

    Topics: 8-Hydroxy-2-(di-n-propylamino)tetralin; Animals; Calcium; Cerebellum; Citalopram; Cyclic GMP; Fenfluramine; Glutamates; Glutamic Acid; In Vitro Techniques; Male; Methiothepin; N-Methylaspartate; Potassium; Rats; Rats, Inbred Strains; Receptors, Amino Acid; Receptors, Cell Surface; Receptors, N-Methyl-D-Aspartate; Receptors, Serotonin; Serotonin; Serotonin Antagonists; Tetrahydronaphthalenes

1991
Increase in endogenous 5-hydroxytryptamine levels modulates the central network underlying locomotion in the lamprey spinal cord.
    Neuroscience letters, 1989, May-22, Volume: 100, Issue:1-3

    Topics: Action Potentials; Animals; Aspartic Acid; Citalopram; Fishes; In Vitro Techniques; Lampreys; Locomotion; N-Methylaspartate; Serotonin; Spinal Cord

1989
Involvement of NMDA and AMPA receptors in the antidepressant-like activity of antidepressant drugs in the forced swim test.
    Pharmacological reports : PR, 2013, Volume: 65, Issue:4

    Topics: 2-Amino-5-phosphonovalerate; Animals; Antidepressive Agents; Citalopram; Cyclopropanes; Imipramine; Immobility Response, Tonic; Male; Mice; Milnacipran; Morpholines; Motor Activity; N-Methylaspartate; Oxazines; Quinoxalines; Reboxetine; Receptors, AMPA; Receptors, N-Methyl-D-Aspartate

2013
Alpha7 nicotinic acetylcholine receptor agonists and PAMs as adjunctive treatment in schizophrenia. An experimental study.
    European neuropsychopharmacology : the journal of the European College of Neuropsychopharmacology, 2016, Volume: 26, Issue:9

    Topics: alpha7 Nicotinic Acetylcholine Receptor; Animals; Antidepressive Agents; Antipsychotic Agents; Benzamides; Bridged Bicyclo Compounds; Citalopram; Depression; Disease Models, Animal; Dopamine; Excitatory Amino Acid Agonists; Male; N-Methylaspartate; Nicotinic Agonists; Phenylurea Compounds; Prefrontal Cortex; Pyramidal Cells; Rats, Sprague-Dawley; Rats, Wistar; Risperidone; Schizophrenia; Schizophrenic Psychology; Selective Serotonin Reuptake Inhibitors

2016
Inhibition of the NMDA and AMPA receptor channels by antidepressants and antipsychotics.
    Brain research, 2017, 04-01, Volume: 1660

    Topics: Amitriptyline; Animals; Antidepressive Agents; Antipsychotic Agents; Atomoxetine Hydrochloride; Brain; Chlorpromazine; Citalopram; Desipramine; Dose-Response Relationship, Drug; Drug Evaluation, Preclinical; Fluoxetine; Magnesium; Male; Membrane Potentials; N-Methylaspartate; Neurons; Neurotransmitter Agents; Rats, Wistar; Receptors, AMPA; Receptors, N-Methyl-D-Aspartate

2017